Product Images Capecitabine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Capecitabine NDC 31722-775 by Camber Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

capecitabine150mglabel - capecitabine150mglabel

capecitabine150mglabel - capecitabine150mglabel

This is a description of Capecitabine 150mg Tablets, a hazardous drug used for treatment. The tablets should be swallowed whole with water within 30 minutes of a meal. It is essential not to crush or cut the tablets. The recommended dosage and prescribing information should be followed. The tablets should be dispensed in tight containers and stored at controlled room temperature. The manufacturer is Camber Pharmaceuticals, Inc., and contact information is provided.*

capecitabine500mglabel - capecitabine500mglabel

capecitabine500mglabel - capecitabine500mglabel

This text is a label for Capecitabine tablets. It warns that it is a hazardous drug and gives instructions for use, like swallowing whole with water after a meal and not crushing or cutting the tablets. It also provides information on storage and contact details. The tablets contain 500 mg of Capecitabine USP and are manufactured for Camber Pharmaceuticals, Inc. by Hetero Labs Limited in India.*

capecitabinecamberlogo - capecitabinecamberlogo

capecitabinecamberlogo - capecitabinecamberlogo

capecitabinechemicalstructure - capecitabinechemicalstructure

capecitabinechemicalstructure - capecitabinechemicalstructure

capecitabinefigure1 - capecitabinefigure1

capecitabinefigure1 - capecitabinefigure1

capecitabinefigure2 - capecitabinefigure2

capecitabinefigure2 - capecitabinefigure2

capecitabinefigure3 - capecitabinefigure3

capecitabinefigure3 - capecitabinefigure3

This text includes information about estimated probabilities (ranging from 0.0 to 1.0) and a specific chemotherapy regimen called "5-FU + Leucovorin (Mayo Regimen)" which involves the drug Capecitabine at a dosage of 1250 mg/sqm administered twice daily intermittently.*

capecitabinefigure4 - capecitabinefigure4

capecitabinefigure4 - capecitabinefigure4

This text appears to be a graph showing estimated probabilities in relation to time (days) for different dosages of Docetaxel (100 mg/sqm every 3 weeks and 75 mg/sqm every 3 weeks) and Capecitabine (1250 mg/sqm twice daily intermittently). It seems to be a representation of a medical study or treatment plan using these medications.*

capecitabinefigure5 - capecitabinefigure5

capecitabinefigure5 - capecitabinefigure5

This text appears to contain information related to estimated probabilities and doses of different medications like Docetaxel and Capecitabine over specific time intervals. It seems to be a medical document providing details of dosage regimens for these treatments.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.